About: http://data.cimple.eu/news-article/32453fd8c1842d32a16765ae1de40495cbe0017d47868a2acb53917e

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/32453fd8c1842d32a16765ae1de40495cbe0017d47868a2acb53917e Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Britain on Friday approved the use of a fourth Covid vaccine, hoping to boost a countrywide inoculation drive to allow its economy to reopen fully despite concerns about a new variant. The Medicines and Healthcare products Regulatory Agency (MHRA) approved the single-shot Johnson & Johnson jab, after previously backing the Pfizer, AstraZeneca and Moderna shots. Prime Minister Boris Johnson called it "very welcome news and another boost to our hugely successful vaccination programme". "As we encourage everyone to get their jabs, the single-dose... vaccine will play an important role in helping us protect people from the virus," he wrote on Twitter. "When you get the call, get the jab." Health Secretary Matt Hancock said the mass vaccination campaign -- the biggest in Britain's history -- had already saved more than 13,000 lives. The latest regulatory green light "means that we now have four safe and effective vaccines approved to help protect people from this awful virus", he added. Britain has ordered 20 million doses of the vaccine, which was found to be 72 percent effective in preventing moderate to severe coronavirus infection, according to a US trial. The European Medicines Agency said in April that a warning about unusual blood clots with low blood platelet count should be added to the J&J product information following cases in the United States. Britain has administered more than 62 million shots so far, mainly using the Pfizer and AstraZeneca vaccines. The J&J vaccine comes on stream as younger people are called for their jab, amid concern over the rise of the so-called Indian variant. After months of falling cases, infections have started to rise again due to the emergence of the variant, which has put in doubt plans for a full reopening of the country on June 21. Business Secretary Kwasi Kwarteng said Friday, however, "it was impossible for anyone to know what the situation will be like in a week or two weeks' time". "We'll be looking at the data, we've said repeatedly that we won't make a final decision about the 21st of June until the 14th of June," he told Sky News. jwp/phz/bp
schema:headline	UK approves single shot Johnson & Johnson Covid vaccine
schema:mentions	Kwasi Kwarteng Smallpox vaccine Secretary of State for Health and Social Care Medicines and Healthcare products Regulatory Agency Matt Hancock European Medicines Agency Prime minister Hertz Sky News Johnson & Johnson Jab Ebola virus disease Boris Johnson AstraZeneca Twitter Pfizer Coronavirus disease United Kingdom Vaccine United States Coronavirus disease 2019 Single-shot Secretary of State for Business, Energy and Industrial Strategy Platelet
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-05-28 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	74 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness
http://data.cimple...entionsConspiracy	antivax conspiracy theory

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software